Smoking is the leading cause of COPD, accounting for over 70% of cases in high-income countries. But it’s not the only cause. Indoor air pollution, workplace dust exposure, genetics, and secondhand smoke all play significant roles, particularly in parts of the world where tobacco use is less common. COPD is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021.
Smoking and How It Damages the Lungs
Cigarette smoke floods the lungs with free radicals and reactive chemicals that trigger a chain of damage. The first thing that happens is a breakdown of the barriers lining your airways and blood vessels. This pulls inflammatory cells into the lungs, starting a cycle of chronic inflammation that, over years, reshapes the lung tissue itself.
Two things go wrong simultaneously. In the airways, chronic inflammation leads to excess mucus production, scarring of the smaller airways, and thickening of airway walls. Cigarette smoke directly impairs the protein responsible for regulating mucus in the airways, which is why a persistent “smoker’s cough” develops long before a COPD diagnosis. In the deeper lung tissue, the elastic fibers that allow your air sacs to stretch and recoil are broken down by enzymes released from inflammatory cells. This destruction of air sacs is called emphysema, and it means less surface area for oxygen to pass into your blood.
What makes this damage self-perpetuating is that cigarette smoke also triggers the death of the structural cells that make up air sacs and tiny blood vessels. Certain fat-based signaling molecules produced in response to smoke amplify their own production, spread inflammation to neighboring tissue, increase the activity of tissue-destroying enzymes, and interfere with the lung’s ability to clean up dead cells. The result is a lung that progressively loses its ability to move air in and out, a process that cannot be fully reversed.
In low- and middle-income countries, tobacco accounts for 30 to 40% of COPD cases rather than the 70% seen in wealthier nations. The gap is filled largely by indoor air pollution.
Indoor Air Pollution and Biomass Fuel
About a third of the world’s population burns wood, crop waste, animal dung, or coal for cooking and heating. These fuels are typically burned on open fires or simple stoves with poor ventilation, filling homes with smoke that is chemically similar to tobacco smoke in terms of the particles and gases it produces. The mechanisms of lung damage are likely the same.
A large meta-analysis found that people exposed to biomass smoke are roughly 2.4 times more likely to develop COPD than those who are not. The risk was elevated in both women and men, though men showed an even higher odds ratio of 4.3. Women bear the greatest burden in practice because they do most of the cooking in regions where biomass fuel is common and are less likely to smoke tobacco, meaning biomass exposure is often their primary lung hazard.
This risk is consistent across populations in Asia and other regions, and it applies to both nonsmokers and smokers. For smokers who also cook with biomass fuel, the combined exposure creates a compounding effect.
Workplace Dust and Chemical Fumes
Occupational exposure is an underrecognized cause of COPD. Silica dust, one of the most common workplace respiratory hazards, can cause chronic bronchitis, emphysema, and small airway disease even at exposure levels that don’t produce silicosis (the scarring disease traditionally associated with silica). In other words, a worker’s chest X-ray can look normal while their lung function is already declining.
Industries with elevated risk include mining, construction, sandblasting, tunneling, and manufacturing that involves grinding stone or concrete. Coal dust, grain dust, cotton dust, and chemical fumes from welding or industrial solvents also contribute. The pattern of damage mirrors what smoking does: chronic inflammation, mucus overproduction, and gradual destruction of the small airways.
Secondhand Smoke
Living or working with smokers carries real consequences for your lungs. A study using U.S. national health data from 2017 to 2020 found that people exposed to secondhand smoke had nearly twice the odds of developing COPD compared to those with no exposure. This held up after adjusting for other risk factors. If you’ve never smoked but have spent years in a household with a smoker, that exposure alone can be enough to cause measurable airflow obstruction over time.
Alpha-1 Antitrypsin Deficiency
A small but important percentage of COPD cases stem from a genetic condition called alpha-1 antitrypsin deficiency. Alpha-1 antitrypsin is a protein your liver produces to protect lung tissue from being damaged by the enzymes your own immune cells release during normal inflammation. When your body doesn’t produce enough of it, or produces a defective version, those enzymes gradually eat away at the elastic tissue in your air sacs, causing emphysema that can appear as early as your 30s or 40s.
The condition is inherited in a codominant pattern, meaning you get one copy of the gene from each parent and both copies influence how much protective protein you make. People with two defective copies are at highest risk. Many individuals with this deficiency are never diagnosed because their symptoms look identical to smoking-related COPD, and doctors don’t always test for it. If you develop COPD at a younger age or have a family history of early-onset lung disease, testing for this deficiency is especially relevant.
E-Cigarettes and Vaping
Evidence is building that vaping carries its own COPD risk. A meta-analysis covering more than 3.5 million participants found that e-cigarette users had a 52 to 55% higher likelihood of developing COPD compared to nonusers. The data comes from both cross-sectional and prospective studies, meaning the association holds up whether researchers looked at a single snapshot in time or followed people forward over years. While the risk is lower than traditional cigarettes, vaping is not a neutral exposure for the lungs.
How These Causes Lead to a Diagnosis
Regardless of the trigger, COPD develops when cumulative lung damage reaches a point where airflow becomes persistently restricted. The formal diagnosis requires a breathing test called spirometry, which measures how much air you can force out in one second compared to your total exhaled volume. A ratio below 0.7 after using a bronchodilator (an inhaled medication that relaxes the airways) confirms COPD.
What makes COPD insidious is that the lungs have enormous reserve capacity. You can lose a significant amount of function before symptoms like shortness of breath or chronic cough become noticeable. By the time most people seek medical attention, the damage has been accumulating for years or even decades. This is true whether the cause is tobacco, biomass smoke, occupational dust, or a genetic deficiency. The lung doesn’t distinguish between sources of injury. Chronic inflammation, tissue destruction, and airway remodeling follow the same path regardless of what started them.